✦ LIBER ✦

847 PHASE II STUDY OF THE MITOCHONDRIAL ANTIOXIDANT MITOQUINONE FOR HEPATITIS C

✍ Scribed by E.J. Gane; D.W. Orr; F. Weilert; G.F. Keogh; M. Gibson; M.P. Murphy; R.A. Smith; M.M. Lockhart; C.M. Frampton; K.M. Taylor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The mitochondria-targeted anti-oxidant m

✍ Edward J. Gane; Frank Weilert; David W. Orr; Geraldine F. Keogh; Michael Gibson; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Randomized placebo controlled phase I/II

✍ Bart J. Veldt; Hans J.J. van der Vliet; B. Mary E. von Blomberg; Hans van Vlierb 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A phase II dose finding study of darbepo

✍ Z. M. Younossi; F. H. Nader; C. Bai; R. Sjogren; J. P. Ong; R. Collantes; M. Sjo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

1155 PEG-IFN FOR CHRONIC HEPATITIS C IN

✍ Rosina, F.; Tosti, M.E.; Borghesio, E.; Mele, A.; Minoli, G.; Gasbarrini, A.; Pa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A phase II, single-arm multicenter study

✍ Marcella Visentini; Serena Ludovisi; Antonio Petrarca; Federica Pulvirenti; Marc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 333 KB

OC-35 PEG-IFN for chronic hepatitis C in

✍ F. Rosina; M.E. Tosti; E. Borghesio; A. Mele; G. Minoli; A. Gasbarrini; F. Pallo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB